Results 21 to 30 of about 929,596 (350)

Interstitial brachytherapy with 192Ir in vulvar cancer [PDF]

Archive of Oncology, 2006
Vulvar cancer accounts for 5% of all female genital cancers and 1% of all malignancies in women. A female patient, 78 years old, with diagnosed squamous cell carcinoma of vulva stage II, was admitted to our Institution in January 2004. An exophytic tumor,
Erak Marko, Mandić Aljoša, Baucal Milutin, Novaković Petar, Erak Dragica, Bugarčić Biljana   +5 more
doaj   +1 more source

Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies

Clinical and Translational Radiation Oncology, 2022
Radiotherapy (RT) is a cornerstone treatment strategy for brain tumours. Besides cytotoxicity, RT can cause disruption of the blood–brain barrier (BBB), resulting in an increased permeability into the surrounding brain parenchyma. Although this effect is
Elvin't Hart, Zelda Odé, Marc P.P. Derieppe, Lucianne Groenink, Martijn W. Heymans, René Otten, Maarten H. Lequin, Geert O.R. Janssens, Eelco W. Hoving, Dannis G. van Vuurden   +9 more
doaj   +1 more source

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer [PDF]

, 2020
Background Several scan parameters for PET imaging with F-18-PSMA-11 such as dosage, acquisition time and scan duration were evaluated to determine the most appropriate scan protocol, as well as the effect of furosemide administration on lesion ...
Achten, Eric, De Man, Kathia, De Vos, Filip, Kersemans, Ken, Ost, Piet, Piron, Sarah, Schelfhout, Vanessa, Van Laeken, Nick   +7 more
core   +2 more sources

ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis—final results after 12-month follow-up

Strahlentherapie und Onkologie (Print), 2023
Objective Updated report about the randomized comparison of the effect of radiotherapy on painful osteoarthritis (OA) applying a standard dose vs. a very low dose regime after a follow-up of 1 year. Patients and methods Patients presenting with OA of the
M. Niewald, Sobhan Moumeniahangar, L. Müller, M. Hautmann, Y. Dzierma, J. Fleckenstein, Stefan Gräber, Christian Rübe, Markus Hecht, P. Melchior   +9 more
semanticscholar   +1 more source

Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy

Radiation Oncology, 2023
Despite combination chemotherapy demonstrating a positive effect on survival, the clinical outcomes of pancreatic adenocarcinoma (PDAC) remain poor. Radiotherapy was previously a component of the curative treatment of PDAC.
I. Jan, Hui-Ju Ch’ang
semanticscholar   +1 more source

Radiotherapy Advances in Renal Disease—Focus on Renal Ischemic Preconditioning

Bioengineering, 2023
Ionizing irradiation is widely applied as a fundamental therapeutic treatment in several diseases. Acute kidney injury (AKI) represents a global public health problem with major morbidity and mortality.
Badr Khbouz, S. Gu, T. Pinto Coelho, F. Lallemand, F. Jouret   +4 more
semanticscholar   +1 more source

Identification of differentially expressed genes in cervical carcinoma after radiotherapy [PDF]

Jichu yixue yu linchuang, 2022
Objective To study the effect of radiotherapy on gene expression in cervical cancer tissues and to find the role of differentially expressed genes in sensitivity and resistance to radiotherapy.
BAI Jing, LIU Na, DING Li, LEI Li, NI Rui, YAN Shao-chun, SHAO Guo
doaj   +1 more source

Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway

CPT: Pharmacometrics & Systems Pharmacology, 2023
Dosage optimization to maximize efficacy and minimize toxicity is a potential issue when administering radiotherapy (RT) in combination with immune checkpoint blockade (ICB) or inhibitors of the DNA Damage Response Pathway (DDRi) in the clinic ...
David Hodson, Hitesh B. Mistry, S. Guzzetti, Michael Davies, A. Staniszewska, Paul M. Farrington, E. Cadogan, James Yates, L. Aarons, K. Ogungbenro   +9 more
semanticscholar   +1 more source

Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice: Dosage Optimization in MC38 Syngeneic Tumors via Modelling and Simulation

Journal of Pharmacology and Experimental Therapeutics, 2023
Clinical trials assessing the impact of radiotherapy (RT) in combination with DNA damage response pathway inhibitors (DDRis) and/or immune checkpoint blockade are currently ongoing. However, current methods for optimizing dosage and schedule are limited.
David Hodson, H. Mistry, James Yates, Paul M. Farrington, A. Staniszewska, S. Guzzetti, M. Davies, L. Aarons, K. Ogungbenro   +8 more
semanticscholar   +1 more source

Survival of dental implants in patients with oral cancer treated by surgery and radiotherapy: a retrospective study [PDF]

, 2015
BACKGROUND: The aim of this retrospective study was to evaluate the survival of dental implants placed after ablative surgery, in patients affected by oral cancer treated with or without radiotherapy.
A Agresti, A Garg, A Korfage, AJ Barber, Antonella Polimeni, CE Misch, CE Misch, D Van Steenberghe, E Schiegnitz, Edoardo Brauner, F Javed, G Colella, G Ganström, G Sammartino, Gabriele Di Carlo, Giorgio Guarino, Giorgio Pompa, J De Ceulaer, J Harrison, KC Yerit, KP Dholam, L Anderson, LL Visch, M De la Plata, M Jacobsson, M Zheng, Matteo Saccucci, Oral cancer foundation, PJ Schoen, RA Fisher, RE Marx, RH Schepers, S Ihde, SS Linsen, Stefano Di Carlo, T Weischer, Tina Gentile, Valentino Valentini   +37 more
core   +2 more sources